These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 6762480)

  • 1. [Therapy of obstructive respiratory tract diseases. Study of afonilum retard in 3,512 patients].
    Eichhorn J; Perré R
    Med Welt; 1982 Dec; 33(50):1834-7. PubMed ID: 6762480
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapy of obstructive respiratory tract diseases with pure theophylline retard].
    Arens PJ
    Med Klin Prax; 1982 Aug; 77(18):48-53, 67. PubMed ID: 6752679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapy of chronic obstructive respiratory syndrome with the new theophylline preparation Afonilum retard].
    Dettmer HH
    Fortschr Med; 1981 Jul; 99(25):1007-11. PubMed ID: 7262783
    [No Abstract]   [Full Text] [Related]  

  • 4. [Obstructive airway diseases. Basic therapy with pure theophylline in retard form].
    Pollert I
    Fortschr Med; 1982 Mar; 100(12):547-50. PubMed ID: 7042500
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapy using delayed-action theophylline].
    Ulmer WT; Zimmermann I
    Fortschr Med; 1982 Nov; 100(42):1973-6. PubMed ID: 7152431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Theophylline therapy in obstructive respiratory diseases. 2. Theophyllin-retard preparations for the long-term treatment of non-smokers with or without cardiac insufficiency (author's transl)].
    Wemhöner S; Oellerich M; Sybrecht G
    Prax Klin Pneumol; 1981 Jan; 35(1):42-6. PubMed ID: 6782562
    [No Abstract]   [Full Text] [Related]  

  • 7. [Results of a serum concentration-oriented dosage of a theophylline depot preparation in ambulatory patients with chronic obstructive lung disease].
    Harder S; Staib AH; Stauder J
    Prax Klin Pneumol; 1985 Jun; 39(6):193-6. PubMed ID: 4022931
    [No Abstract]   [Full Text] [Related]  

  • 8. [Optimizing therapy with theophylline preparations in obstructive ventilation disorders. 3. Prediction of theophylline clearance with a simple pharmacokinetic method and comparison of bioavailability of various theophylline retard preparations].
    Ranke C; Schmidt G; Oellerich M; Sybrecht GW
    Prax Klin Pneumol; 1983 Mar; 37(3):99-108. PubMed ID: 6856564
    [No Abstract]   [Full Text] [Related]  

  • 9. The use of sustained-release theophylline ('Theo-dur') for the treatment of chronic reversible obstructive lung disease in hospital practice.
    Riddington CJ; Shipman AJ
    Br J Clin Pract; 1985 Apr; 39(4):148-53. PubMed ID: 3893504
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical functional study of a new delayed-action preparation of "once a day" anhydrous theophylline in patients with chronic obstructive bronchopneumopathy].
    Gatto PG; Bruzzoni A; Valenti V
    Clin Ter; 1989 Jul; 130(1):45-9. PubMed ID: 2529079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bamifylline in the treatment of chronic bronchial obstruction: a controlled clinico-functional study versus an anhydrous theophylline administered once a day].
    Caputi M; Cautiero V; Aliberti M; Monici Preti PA; Oliani C
    Arch Monaldi Mal Torace; 1988; 43(5):409-21. PubMed ID: 3079283
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of standard- and sustained-release theophylline tablets in patients with chronic obstructive pulmonary disease.
    Dasta J; Mirtallo JM; Altman M
    Am J Hosp Pharm; 1979 May; 36(5):613-7. PubMed ID: 453214
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical results obtained from a new controlled release theophylline preparation.
    Nolte D
    Br J Clin Pract Suppl; 1984; 32():14-7. PubMed ID: 6432017
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prescription of Theostat 300 as a single evening dose].
    Germouty J; Bida C; Moreau L
    Rev Pneumol Clin; 1987; 43(5):262-5. PubMed ID: 3324266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of two long-acting theophylline preparations in daily evening administration].
    Holzer R
    Wien Med Wochenschr; 1993; 143(2):37-42. PubMed ID: 8488685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Long-term therapy with a retard theophylline preparation].
    Keller A; Bömches B; Kandt D
    Fortschr Med; 1995 May; 113(13):197-202. PubMed ID: 7782018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic action of a new xanthine derivative in respiratory pathology].
    Cesco G; Biondi T; Mazzini R
    Clin Ter; 1986 Aug; 118(4):253-7. PubMed ID: 3530620
    [No Abstract]   [Full Text] [Related]  

  • 18. [Use of a new delayed-release anhydrous theophylline by single daily administration in the treatment of reversible bronchial obstruction. Comparison with a delayed-release preparation administered twice daily].
    Baronti A; Verdiani P; Di Carlo S
    Clin Ter; 1987 Sep; 122(6):437-40. PubMed ID: 2972456
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of obstructive respiratory disorders using a new theophylline retard preparation].
    Schroers M; Merbach W; Don M
    ZFA (Stuttgart); 1982 Jun; 58(17):974-8. PubMed ID: 7113392
    [No Abstract]   [Full Text] [Related]  

  • 20. [Interactions of theophylline and nifedipine].
    Luther R; Wichert H; Köhler E; Banditt P; Walther H
    Z Erkr Atmungsorgane; 1990; 174(2):97-103. PubMed ID: 2349818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.